Dareon-Lung-1 will test obrixtamig plus Tecentriq and chemo in small-cell lung cancer.
ApexOnco Front Page
Recent articles
The Sentry trial hits on spleen volume reduction, but misses on symptoms.
Inhibrx reveals three deaths in phase 1, but all predate screening protocols.
BG-75202 features among several projects starting first-in-human trials.
There will soon be three PD-(L)1 x VEGF projects in pivotal lung and colorectal cancer trials.
Pfizer cans PF-08046045, but keeps PF-08046044 for now.
The Fortitude-102 trial, testing a bemarituzumab/Opdivo/chemo triplet, has failed.
Blackstone follows Abingworth, but why?
